Delivery Order SPE2DB24D2205-SPE2DB24FDVLV

Award Date 6/12/24
Potential Completion Date 6/13/24
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,163.64 firm fixed-price delivery order is for the supply of IPOL VIAL 5ML pharmaceutical products. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,117.80 firm fixed price delivery order is for the supply of IPOL VIAL 5ML medical products. The contract has a period of performance through February 28, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $32,468.30 firm-fixed-price delivery order is for the supply of IPOL VIAL 5ML, a medical product. The contract has a period of performance through November 2024 and is not designated with a set-aside requirement. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $10,673.50 firm fixed price delivery order is for the supply of 4564932440 IPOL VIAL 5ML pharmaceutical products. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,486.05 firm fixed-price delivery order is for IPOL VIAL 5ML medical products. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $85,139.88 firm fixed-price delivery order is for the supply of IPOL VIAL 5ML medical products. The award is not associated with any specific set-aside requirements. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a...
This federal contract was awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order worth $2,047.30 and has a Firm Fixed Price pricing type. The contract is for the delivery of IPOL VIAL 5ML pharmaceutical products and has an ultimate completion date of April 24, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,067.35 firm fixed-price delivery order is for the supply of IPOL VIAL 5ML, with a period of performance through August 5, 2024. This contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $8,538.80 firm fixed-price delivery order is for the supply of 4566133902 IPOL VIAL 5ML medical products, with an ultimate completion date of October 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of IPOL VIAL 5ML medical supplies. The contract, valued at $2,134.70, is a firm fixed-price delivery order with an ultimate completion date of August 6, 2024. Amerisourcebergen, through its Corporate Office division, has been awarded numerous federal contracts by various defense and civilian agencies to supply a...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB24FDVLV
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $10,673.50 Firm Fixed Price delivery order is for the supply of 4564884108 IPOL VIAL 5ML, a pharmaceutical product. This award is under a larger Indefinite Delivery Contract (IDC) between DLA and Amerisourcebergen, valued up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This contract award does not have a set-aside designation.

Generated 9/11/24, 10:55 AM